Ronald Harold Wilfred Cooper's Net Worth

$148 Thousand

Estimate Recalculated Nov 3, 2024 09:40PM EST

Who is Ronald Harold Wilfred Cooper?

Ronald Harold Wilfred Cooper does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALBIREO PHARMA, INC., Generation Bio Co., GENOCEA BIOSCIENCES, INC., C4 Therapeutics, Inc., and enGene Holdings Inc..

SEC CIK

Ronald Harold Wilfred Cooper's CIK is 0001676880

Past Insider Trading and Trends

2018 was Ronald Harold Wilfred Cooper's most active year for acquiring shares with 5 total transactions. Ronald Harold Wilfred Cooper's most active month to acquire stocks was the month of December. 2023 was Ronald Harold Wilfred Cooper's most active year for disposing of shares, totalling 12 transactions. Ronald Harold Wilfred Cooper's most active month to dispose stocks was the month of February. 2021 saw Ronald Harold Wilfred Cooper paying a total of $229,761.87 for 183,673 shares, this is the most they've acquired in one year. In 2021 Ronald Harold Wilfred Cooper cashed out on 19,733 shares for a total of $229,773.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALBIREO PHARMA, INC. No price found

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-33.09K
—
—
0
Mar 2
Form 4/A
+339.46%
195K
—
—
252.44K
Jan 19
Form 4
+339.46%
195K
—
—
252.44K
Jan 19
Form 4
-1.81%
-1.06K
$43.80
-$46,296.60
57.44K
Scheduled
Jan 23
Form 4/A
-1.55%
-919.00
$19.58
-$17,990.71
58.5K
Scheduled
Oct 24
Form 4
-1.63%
-919.00
$19.58
-$17,990.71
55.46K
Scheduled
Oct 24
Form 4
-1.62%
-929.00
$24.67
-$22,922.61
56.38K
Scheduled
Jul 22
Form 4
-1.59%
-907.00
$33.11
-$30,030.77
56.08K
Scheduled
Apr 22
Form 4
-6.07%
-3.68K
$24.88
-$91,666.02
56.99K
Scheduled
Jan 24
Form 4
—
0
—
—
0
Jan 18
Form 4
+7.46%
4.21K
$24.40
-$11.73
60.67K
Sep 17
Form 4
+627.58%
48.7K
—
—
56.46K
Jan 21
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
Jan 22
Form 4
+15.24%
1.03K
$25.02
$25,668.16
7.76K
Scheduled
Nov 13
Form 4
+13.25%
788
$31.85
$25,098.44
6.73K
Scheduled
Aug 14
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Aug 21
Form 4
—
0
—
—
0
Jan 20
Form 4
∞
5.95K
—
—
5.95K
Nov 3
Form 3
—
0
—
—
0
No matching records found

Generation Bio Co. (GBIO) Snapshot price: $2.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 8
Form 4
∞
9.5K
$5.12
$48,640.00
9.5K
Jan 5
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

GENOCEA BIOSCIENCES, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
Jul 18
Form 4
—
0
—
—
0
Jun 21
Form 4
—
0
—
—
0
Jun 13
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 7
No matching records found

C4 Therapeutics, Inc. (CCCC) Snapshot price: $5.48

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 3
—
0
—
—
0
No matching records found

enGene Holdings Inc. (ENGN) Snapshot price: $7

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 22
Form 3
—
0
—
—
0
No matching records found